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Abstract- Cirrhosis has been related with hyperdynamic circulation, manifesting as increased cardiac output 
and decreased systemic vascular resistance. In the present study we examined the cirrhosis outcome on 
apoptosis of rat hearts. We also tried to explore the role of nitric oxide (NO) and oxidative stress in the 
probable changed apoptosis of cirrhotic hearts. Twenty eight days after ligation of bile duct, heart tissues 
were tested for apoptosis. The extent of malondialdehyde (MDA), and the activities of catalase (CAT), 
glutathione peroxidase (GSHPx) and superoxide dismutase (SOD) have been calculated in heart tissues. The 
cirrhotic hearts exhibited structural defects and greater apoptosis. Chronic treatment of cirrhotic rats with L-
NAME, a non-selective inhibitor of NO synthase, inhibited heart structural defects and reduced apoptosis of 
hearts. We also showed that cirrhotic rat hearts had an enhanced level of MDA and reduced activities of 
CAT, GSHPx and SOD. When the animals were treated by L-NAME chronically, the MDA level reduced 
and activities of CAT, GSHPx and SOD augmented in cirrhotic heart. In conclusion, increased apoptosis of 
cirrhotic hearts probably happen due to NO overproduction and increased oxidative stress in hearts of 
cirrhotic rats.  
© 2017 Tehran University of Medical Sciences. All rights reserved.  
Acta Med Iran 2017;55(1):29-34. 
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Introduction 
 
Cirrhosis is accompanying with cardiovascular 
abnormalities. The circulation becomes hyperdynamic, 
well-defined as increased cardiac output and decreased 
peripheral vascular resistance and blood pressure. The 
peripheral vasodilatation has also been reported in local 
vascular beds for instance the mesenteric/splanchnic, 
pulmonary, renal, and skeletal muscle. In spite of the 
augmented baseline cardiac output, the ventricular 
contractile response to stimuli is reduced, this state 
called cirrhotic cardiomyopathy (1). Reduced systolic 
and diastolic responses to stress, electrophysiological 
irregularities, including prolongation of repolarization 
(increased electrocardiographic QT interval), and 
cardiac chamber hypertrophy or enlargement have been 
observed in cirrhotic cardiomyopathy (1,2).  
Nitric oxide (NO) was suggested as a mediator of 
splanchnic vasodilatation in portal hypertension in 1991 
(3). Since then several evidences have been reported 
from human and experimental models of cirrhosis that 
alteration of NO activity influences diverse vascular 
beds in different methods. Cirrhotic patients have 
augmented plasma levels of nitrites and nitrates which 
are NO degradation products (4). In our previous paper, 
we showed that the basal abnormalities and the 
decreased chronotropic and inotropic responses to 
isoproterenol were improved by treatment with L-
NAME, a non-selective inhibitor of NO synthase (NOS) 
in cirrhotic rats, suggesting the role of NOS in these 
NO and oxidative stress in cirrhotic rats 
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events (5). Chronic L-NAME administration also 
corrected the QT prolongation in cirrhotic rats (6) and 
restored the susceptibility of cirrhotic and cholestatic 
rats to arrhythmias (6,7). 
Oxidative stress has been known as essential factor 
in the promotion of chronic liver damage of various 
etiologies to liver cirrhosis. These etiologies include 
alcoholic liver disease, nonalcoholic steatohepatitis, 
chronic viral hepatitis and cholestatic diseases (8,9). 
Earlier studies have proved that the activity of liver 
antioxidant systems is decreased with disease severity 
(10,11). Gut-derived endotoxemia owing to gut barrier 
failure plays a serious role in the progression of the 
hepatic injury. The hepatic macrophage cells (Kuppfer) 
exert essential role in this process that are stimulated by 
endotoxin to release several cytokines and 
proinflammatory mediators (12). There are several 
reports showed that treatment with antioxidants is 
helpful in preventing this process by direct antioxidant 
effects in liver tissue or through decrease of intestinal 
endotoxemia (12,13). Other reports showed that 
antioxidants similar L-NAME and N-acetylcysteine 
reduced cardiac nitrotyrosine levels leading to 
normalization of cardiac function in cirrhosis (14). 
In the current study we are trying to find if cirrhosis 
have any effect on cardiac apoptosis and whether L-
NAME, a non-selective inhibitor of NOS, could change 
apoptosis in cirrhotic rat hearts.  
 
Materials and Methods 
 
Animal  
Male Sprague-Dawley rats weighing 200-250 g were 
used in this study. The rats were handled in agreement 
with the standards defined in the ‘‘Guide for the Care 
and Use of Laboratory Animals’’ (NIH US publication 
86-23 revised 1985 and accepted by Shiraz University of 
Medical Sciences). The animals were kept in standard 
polycarbonate cages in a temperature-controlled room 
(24±2º C) with 12 h light/12 h dark cycle with free 
access to food and water.  
 
Animal model of cirrhosis 
The animals were randomly divided into 4 groups; 
each group consisted of ten rats. (1) sham-operated 
controls treated with saline, (b) sham-operated controls 
treated with L-NAME (10 mg/kg), (c) cirrhotic animals 
treated with saline, (d) cirrhotic animals treated with L-
NAME (10 mg/kg). In brief, bile duct ligation was done 
as defined before (15). Laparatomy was done under 
anesthesia (ketamine HCl, 50 mg/kg, i.p. and xylazine 
10 mg/kg, i.p.). The bile duct was recognized, 
manipulated and one untied loose tie was left in place in 
the sham rats, however, in cirrhotic rats, the bile duct 
was doubly ligated. Then the abdominal wall was closed 
in two layers.  Four weeks after the surgery, cirrhotic 
rats showed jaundice, muscle wasting, ascites and liver 
failure. This is a well-known rat model of biliary 
cirrhosis, and the liver histology and serum biochemistry 
characteristic of cirrhosis and liver failure have formerly 
been recognized (16,17). The groups received 
intraperitoneal injections of L-NAME (10 mg/kg) or 
saline once daily for 7 days during the fourth week after 
the surgery. 
 
Heart haematoxylin and eosin staining  
For histological staining, formalin-fixed slices of the 
cardiac lobes were cut into 3 mm sections. 
Haematoxylin-eosin (H and E) was used for staining. A 
pathologist who was blinded to the information of 
groups and laboratory data evaluated the histology. 
 
Apoptosis of heart cells (Terminal deoxynucleotidyl 
transferase dUTP nick end labeling assay)  
Twenty eight days after bile duct ligation or sham 
surgery, rats’ cardiac tissues were fixed in 10% 
formalin, and then tissues were embedded in paraffin 
and sectioned at 5 mm. The slides were processed for a 
terminal deoxynucleotidyl transferase dUTP nick end 
labelling (TUNEL) assay. An ApopTag in situ detection 
kit (Roche Diagnostics, Mannheim, Germany) was used 
according to the producer’s guidelines. The slides were 
treated with hydrogen peroxide (H2O2) and incubated 
with the reaction mixture containing TdT and 
digoxigenin-conjugated dUTP for 1 h at 37º C. Labelled 
DNA was visualized with peroxidase-conjugated anti-
digoxigenin antibody using 3, 30-diaminobenzidine 
(DAB) as the chromogen. Rat testicular tissue was used 
as positive control (18). For negative control, TdT was 
omitted from the reaction mixture. At least 10 random 
sections of each heart were quantified. Values were 
expressed as the number of TdTl abelled nuclei per 106 
nuclei. 
 
Malondialdehyde determination 
Tissue MDA was dignified using the thiobarbituric 
acid-reactive substance assay, as defined by Ohkawa et 
al., (19). As an external standard, 1,1,3,3-
tetramethoxypropane was used and the levels of lipid 
peroxides are expressed as nanomoles of MDA per gram 
wet tissue. 
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Catalase, glutathione peroxidase and total 
superoxide dismutase determination 
Tissue sections were homogenized in triton X-100 
(1%), and the homogenates were diluted with potassium 
phosphate buffer. The reaction was initiated by adding 
H2O2 to the reaction mixture, and the extent of enzyme 
activity was quantitated based on the ability of tissue 
CAT to decompensate H2O2 by monitoring the reduction 
in absorbance at 240 nm. By measuring the absorbance 
changes after 1 min, CAT activity was calculated and 
expressed as nmol per mg protein. 
GSHPx enzymes catalyse the reduction of H2O2 to 
water using glutathione (GSH) as a reducing reagent, 
the. In the assay, oxidized GSH is reduced to GSH by 
the enzyme GSH reductase, which oxidizes NADPH 
(nicotinamide adenine dinucleotide phosphate, reduced 
form) to NADP in the catalytic cycle. The alteration in 
absorbance at 340 nm subsequent the oxidation of 
NADPH is the base of quantitating tissue GSHPx 
activity. GSHPx activity was calculated and stated as 
nmol per mg protein. 
Superoxide anions were produced from manganese 
(II) chloride and mercapthoethanol in the existence of 
acid-EDTA. The extent of SOD was calculated 
according to its capability to inhibit NADH oxidation in 
the reaction mixture after the adding tissue homogenate. 
NADH oxidation was calculated by checking the 
diminution in absorbance at 340 nm during the reaction. 
Total SOD activity was stated as units per mg protein. 
 
Statistical analysis 
Data were presented as mean±SEM. One-way 
ANOVA followed by Tukey multiple comparisons were 
used to analyse the data. Differences were considered to 
be significant at P<0.05. 
 
Results 
 
Haematoxylin and eosin staining of the heart tissues 
and cardiac cell apoptosis  
Cirrhotic hearts presented essential abnormalities 
when compared with sham hearts (Figures 1a,1b). 
Moreover, chronic administration of L-NAME did not 
induce any structural changes in the hearts of sham 
animals (Figure 1c) while structural abnormalities in the 
heart of cirrhotic rats were prevented by chronic L-
NAME administration (Figure 1d). 
TUNEL positive cells were rarely recognized in 
sham rat hearts. Apoptosis of cardiac cells were greater 
in cirrhotic rats compared with sham ones (P<0.01); but 
L-NAME administration decreased apoptosis in cirrhotic 
rat hearts (P<0.01). Chronic treatment with L-NAME 
did not alter the extent of apoptosis in cardiac sham 
animals (Figures 2,3). 
 
 
Figure 1. Gross morphology in rat hearts. The pictures presenting 
haematoxylin and Eosin (H and E) staining of heart tissues on day 28 in 
(a) sham group, (b) cirrhotic group, (c) L-NAME-treated sham group and 
(d) L-NAME-treated cirrhotic group. The rats received L-NAME (10 
mg/kg) or saline once daily for 7 days during the fourth week after the 
bile duct ligation surgery. 
 
 
 
Figure 2. Apoptosis of heart cells 
Pictures showing TUNEL-positive nuclei on day 28 in (a) sham 
group, (b) cirrhotic group, (c) L-NAME-treated sham group and (d) L-
NAME-treated cirrhotic group. Arrows show TUNEL-positive nuclei. 
The groups received L-NAME (10 mg/kg) or saline once daily for 7 
days during the fourth week after the bile duct ligation surgery. 
 
 
 
Figure 3. Cardiac cell apoptosis using TUNEL assay in sham and 
cirrhotic animals after treatment with saline or L-NAME. **P<0.01 
compared with corresponding sham group and ##P<0.01 compared 
with saline-treated cirrhotic group. 
NO and oxidative stress in cirrhotic rats 
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Lipid peroxidation and antioxidant enzyme activities 
Cirrhotic rats showed higher level of malondialdehyde 
in their hearts (P<0.001). Administration of L-NAME 
decreased MDA levels in cirrhotic group (P<0.001) (Fig. 
4a). The activities of CAT, GSHPx and SOD in cirrhotic 
hearts reduced compared with sham ones. Treatment with 
L-NAME increased the activities of CAT in sham hearts 
(P<0.001). Besides that L-NAME treatment enhanced 
CAT, SOD and GSHPx activities in cirrhotic rat hearts 
significantly (P<0.001) (Figures 4b,4c,4d). 
 
 
Figure 4. a) Malondialdehyde levels (MDA) and antioxidant enzyme activities: Catalase (CAT) (b), Glutathione Peroxidase (GSHPx) (c) and 
Superoxide Dismutase (SOD) (d) in rat cirrhotic and sham hearts. Data are expressed as mean±SEM.* P.value<0.05, ** P.value<0.01 and *** 
P.value< 0.001 compared to saline-treated sham group and ### P.value< 0.001 compared to saline-treated cirrhotic group. 
 
Discussion 
 
In the present study we demonstrated that cirrhotic 
hearts presented structural abnormalities and increased 
apoptosis compared with sham hearts. Chronic 
administrations of L-NAME in cirrhotic rats not only 
improved heart structural abnormalities but also 
ameliorated enhanced-apoptosis of cirrhotic hearts. 
Cirrhotic rat hearts also indicated an increased level of 
MDA and decreased activities of CAT, GSHPx and 
SOD. In chronic L-NAME administration, the extent of 
MDA reduced and activities of CAT, GSHPx and SOD 
augmented in cirrhotic heart rats . 
In cirrhosis, cardiac output increases while systemic 
vascular resistance and arterial pressure drop (20,21). 
Although there is the enhanced basal cardiac output, 
cardiac response to physiologic or pharmacologic 
stimuli is defined to be subnormal (1,22), a phenomenon 
called "cirrhotic cardiomyopathy" (23). Systolic and 
diastolic dysfunction, electrophysiological changes, and 
macroscopic and microscopic structural alterations have 
been defined in cirrhotic cardiomyopathy. The results of 
our study are in line with previous reports. The results of 
H&E staining confirmed structural abnormalities in 
cirrhotic hearts. Moreover cardiac cell apoptosis was 
significantly higher in cirrhotic rats compared with sham 
ones. 
The role of nitric oxide in the pathophysiology of 
cardiac dysfunction in cirrhosis was first reported in 
1996 (24). Following reports by Lee et al., (25) have 
demonstrated that serum cytokine levels are enhanced in 
cirrhotic rats, and that the negative inotropic effect of 
interleukin-1β could be reversed by pre-incubation of 
isolated papillary muscle with an NO synthase (NOS) 
inhibitor. Similarly, we have reported that elevated NO 
production in bile duct-ligated (BDL) animals induces 
bradycardia (26,27). Another study indicated that 
abnormal cardiac chronotropic function in cirrhosis is 
associated with increased nitration of cardiac proteins. 
In this study we indicated that structural abnormalities in 
the heart of cirrhotic rats were prevented by L-NAME 
administration. In addition, L-NAME treatment reduced 
apoptosis in cirrhotic rat hearts. These results approve 
the role of nitric oxide in structural abnormalities of 
cirrhotic hearts. 
Patients with cirrhosis have increased plasma levels 
of nitrites and nitrates which are the NO degradation 
products (4). There is also evidence of increased eNOS 
(28,29), iNOS (30) or nNOS (31) upregulation in the 
systemic circulation of cirrhotic subjects. It has been 
demonstrated that exhaled air from cirrhotic patients 
contains elevated levels of NO compared with controls. 
The augmented content of NO associates with the 
severity of disease and degree of hyperdynamic 
circulation (32). One of essential results of the increased 
levels of NO is its cellular toxicity. The direct toxicity of 
NO per se is modest, but is greatly increased on reaction 
with superoxide anions (O2−˙) to form peroxynitrite 
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(ONOO−). Although this reaction was viewed initially 
as a route for NO inactivation, the formation of 
peroxynitrite transforms two relatively unreactive free 
radicals, ˙NO and O2−˙, into much more bioreactive 
species. The formation of peroxynitrite depends on the 
concentration of both ˙NO and O2−˙ and, therefore, on 
the activities of both NOS and superoxide dismutase 
(33). 
Oxygen-derived free radicals (among the more 
important of these is O2−˙), and consequently lipid 
peroxidation, are clearly enhanced in liver diseases. 
Under these conditions, peroxynitrite is readily formed 
from the reaction between O2−˙ and ˙NO. This reaction 
is at least three times faster than dismutation by 
superoxide dismutase (34). 
In the current study we indicated that cirrhotic rat 
hearts presented increased level of MDA and decreased 
activities of CAT, GSHPx and SOD. These data are 
similar with several previous studies which have been 
demonstrated the role of oxidative stress in liver injury 
(10,11,35). In chronic administration of L-NAME, the 
level of MDA decreased and activities of CAT, GSHPx 
and SOD increased in cirrhotic heart rats which support 
the role of nitric oxide in these abnormalities. 
Nitric oxide induces apoptosis by modulating 
multiple sites along the signaling pathways. In the death 
receptor pathway, NO increases the Fas expression and 
the ceramide production, which leads to caspase 
activation. In the mitochondrial pathway, NO increases 
the Bax/Bcl-2 ratio, resulting in an increased 
mitochondrial permeability and cytochrome c release. 
NO also inhibits the electron transport chain complex I–
III to reduce energy production and increase p53, both 
of which contribute to the pro-apoptoti effects of NO. In 
addition, NO increases caspase activity through 
downregulation of IAP (36). In the present research we 
demonstrated that L-NAME treatment could reverse 
cirrhosis-induced heart apoptosis in rats which confirm 
the role of nitric oxide in cirrhotic hearts apoptosis. 
In conclusion, cirrhotic hearts demonstrated 
structural abnormalities and apoptosis, which are 
improved by L-NAME treatment, suggesting the role of 
increased NO overproduction in this effect. Besides that 
increased levels of MDA and decreased levels of CAT, 
GSHPx and SOD have been observed in cirrhotic hearts 
which are reversed by L-NAME treatment, indicating 
the possible role of NO.  
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